Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 2,968 | 867 | 1,801 | 2,226 | 8,885 |
| Gross Profit | 2,968 | 867 | 1,801 | 2,226 | 8,885 |
| Operating Expenses | 11,891 | 11,379 | 14,074 | 13,498 | 9,226 |
| Operating Income | -8,923 | -10,512 | -12,273 | -11,272 | -341 |
| Other Income | 10 | 12 | 10 | 14 | 17 |
| Pre-tax Income | -8,913 | -10,500 | -12,263 | -11,258 | -324 |
| Net Income Continuous | -8,551 | -10,500 | -12,263 | -11,258 | -324 |
| Net Income | $-8,551 | $-10,500 | $-12,263 | $-11,258 | $-324 |
| EPS Basic Total Ops | -0.13 | -0.17 | -0.24 | -0.22 | 0.02 |
| EPS Basic Continuous Ops | -0.13 | -0.17 | -0.24 | -0.22 | 0.02 |
| EPS Diluted Total Ops | -0.13 | -0.17 | -0.24 | -0.22 | 0.02 |
| EPS Diluted Continuous Ops | -0.13 | -0.17 | -0.24 | -0.22 | 0.02 |
| EBITDA(a) | $-7,839 | $-10,333 | $-11,955 | $-10,995 | $-80 |